X842

· Jiangsu Sinorda Biomedicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for X842, covering 2017-11-07 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis [Phase 2]